Search research articles
Contact Us
Filters
Showing results (341-350 of 677) with videos related to
Page
of 68
Sort By:
European Journal of Anaesthesiology
|
August 1, 2025
Risk of publishing guidelines
Sibylle Langenecker, Juan V Llau, Daniela C Filipescu, et al.
Thrombosis Research
|
September 3, 2010
Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: a randomised controlled trial in healthy elderly adults
Meyer M Samama, Satoshi Kunitada, Andŗe Oursin, et al.
Thrombosis Research. Supplement
|
January 1, 1990
Degradation of fibrinogen by tissue plasminogen activator. Consequences for fibrin polymerization
M Mirshahi, J Soria, C Soria, et al.
Anesthesie, Analgesie, Reanimation
|
January 1, 1980
[Congenital deficiency of factor XI: diagnosis and therapy in surgical patients (author's transl)]
A Robert, C Huguet, H Conard, et al.
Thrombosis Research
|
May 15, 1981
Antithrombin III in patients treated with subcutaneous or intravenous heparin
J Conard, T Lecompte, M H Horellou, et al.
Haemostasis
|
January 1, 1981
Study of platelet diameter distribution in patients with valvular heart disease and with prosthetic heart valve replacement
M Dumoulin, M Tirmarche, M H Horellou, et al.
Annales De Medecine Interne
|
January 1, 1988
[The eccentriplate device on the Dideco Vivacell cell separator for the collection of platelets]
G Andreu, A Gautheron, A Nicod-Tran, et al.
Thrombosis Research
|
December 15, 1988
Importance of a 3-O-sulfate group in a heparin pentasaccharide for antithrombotic activity
J M Walenga, M Petitou, M Samama, et al.
Haemostasis
|
January 1, 1983
Molar antithrombin concentration in normal human plasma
J Conard, F Brosstad, M Lie Larsen, et al.
Lancet (London, England)
|
May 17, 1980
L-asparaginase, antithrombin III, and thrombosis
J Conard, B Cazenave, J Maury, et al.
Page
of 68
Search research articles
Search
Showing results (341-350 of 677) with videos related to
Sort By:
Page
of 68
European Journal of Anaesthesiology
|
August 1, 2025
Risk of publishing guidelines
Sibylle Langenecker, Juan V Llau, Daniela C Filipescu, et al.
Thrombosis Research
|
September 3, 2010
Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: a randomised controlled trial in healthy elderly adults
Meyer M Samama, Satoshi Kunitada, Andŗe Oursin, et al.
Thrombosis Research. Supplement
|
January 1, 1990
Degradation of fibrinogen by tissue plasminogen activator. Consequences for fibrin polymerization
M Mirshahi, J Soria, C Soria, et al.
Anesthesie, Analgesie, Reanimation
|
January 1, 1980
[Congenital deficiency of factor XI: diagnosis and therapy in surgical patients (author's transl)]
A Robert, C Huguet, H Conard, et al.
Thrombosis Research
|
May 15, 1981
Antithrombin III in patients treated with subcutaneous or intravenous heparin
J Conard, T Lecompte, M H Horellou, et al.
Haemostasis
|
January 1, 1981
Study of platelet diameter distribution in patients with valvular heart disease and with prosthetic heart valve replacement
M Dumoulin, M Tirmarche, M H Horellou, et al.
Annales De Medecine Interne
|
January 1, 1988
[The eccentriplate device on the Dideco Vivacell cell separator for the collection of platelets]
G Andreu, A Gautheron, A Nicod-Tran, et al.
Thrombosis Research
|
December 15, 1988
Importance of a 3-O-sulfate group in a heparin pentasaccharide for antithrombotic activity
J M Walenga, M Petitou, M Samama, et al.
Haemostasis
|
January 1, 1983
Molar antithrombin concentration in normal human plasma
J Conard, F Brosstad, M Lie Larsen, et al.
Lancet (London, England)
|
May 17, 1980
L-asparaginase, antithrombin III, and thrombosis
J Conard, B Cazenave, J Maury, et al.
Page
of 68